pociredir
pociredir: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Fulcrum Therapeutics, Inc. (FULC) | Phase 2 |
Clinical Trials (1)
A Phase 1 Open-Label, Multiple-Dose Study to Evaluate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of FTX-6058 in Subjects With Sickle Cell Disease (SCD)
Frequently asked questions
Who is developing pociredir?
pociredir is being developed by Fulcrum Therapeutics, Inc..
How many clinical trials involve pociredir?
BioSniper tracks 1 clinical trial involving pociredir.
Get deeper analysis on pociredir
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis